Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Thorough QT/QTc Study of 2 Doses of ADASUVE in Healthy Volunteers

Trial Profile

Thorough QT/QTc Study of 2 Doses of ADASUVE in Healthy Volunteers

Phase of Trial: Phase I

Latest Information Update: 26 Oct 2017

At a glance

  • Drugs Loxapine (Primary) ; Moxifloxacin
  • Indications Psychotic disorders
  • Focus Pharmacodynamics
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 07 Oct 2015 Results published in the International Journal of Clinical Pharmacology and Therapeutics
    • 14 Aug 2014 According to an Alexza Pharmaceuticals media release, data from this and four other trials have been submitted to the EMA as a part of the post-approval process of loxapine.
    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top